This case study from the National Viral Hepatitis Roundtable and Project Inform describes the cost-sharing mechanisms that create significant barriers to accessing new hepatitis C treatments, which require a strong advocate response to improve patient access.
Nonadherence is common among high-risk patients initiating statins and is associated with suboptimal low-density lipoprotein cholesterol (LDL-C) reduction. LDL-C should be monitored to identify suboptimal response and medication nonadherence.
This study examines variation among health plans in resource use and quality of care for patients with diabetes mellitus or cardiovascular disease.
Analysis of studies of worksite wellness programs suggested mixed impact on health-related behaviors and cost, with insufficient evidence regarding absenteeism and mental health.
The effect of managed care on physician financial incentives to reduce services declined substantially from 2000-2001 to 2004-2005.
Even in a fully integrated healthcare system, only 28% of cancer quality measures could be validated by using electronically available data.
Both potential benefits and unexpected consequences were found as a result of the rollout of electronic prescribing.
We determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.
Meta-analyses of percutaneous coronary interventions in stable coronary artery disease are updated to include 2 recent large randomized controlled trials.
Cost is a common barrier to medication adherence. The authors discuss the potential role of medication rebates in patients’ out-of-pocket costs and medication adherence.
Hypoglycemia after basal insulin initiation is associated with high clinical and economic burden that precedes insulin initiation and persists during 1 to 2 years of follow-up.
Commercial health plans promote the use of health IT to support behavioral health care access and delivery.
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Use of specialist visits decreased by patients whose primary care physicians transformed their practices into patient-centered medical homes, 1 year after medical home implementation.
Continuous glucose monitors (CGMs) are increasingly accessible and effective for patients with type 2 diabetes (T2D), and even those with prediabetes, as a means for real-time biofeedback and behavior change.
Patients enrolled in the tuberculosis pay-for-performance program received more comprehensive ambulatory care with slightly lower costs and a higher treatment success rate.
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.